| Shobha et al.95
|
Escherichia coli
|
Efficient antibacterial properties against both pathogens, inhibition of biofilm formation |
|
Staphylococcus aureus
|
| Fulindi et al.8
|
Staphylococcus aureus
|
Effective against multiple bacterial strains, inhibition of biofilm formation |
|
Klebsiella oxytoca, Pseudomonas aeruginosa
|
| Yassin et al.97
|
Candida tropicalis
|
Significant inhibition of candidal pathogens, potential synergistic effects with antifungal agents |
|
Candida glabrata
|
| Urge et al.98
|
Gram-negative and Gram-positive bacteria |
Potent inhibition of bacterial growth, enhanced antibacterial activity with combined plant extracts |
| Almaary et al.99
|
Nosocomial bacterial pathogens |
Significant antibacterial activity against nosocomial bacterial pathogens, synergistic effects with fosfomycin |
| Jawad100
|
Proteus mirabilis isolates |
Strong antibacterial and antibiofilm activity against specific bacterial strains, potential application in medical device preservation |
| Motelică et al.101
|
Gram-negative strains (Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, and Escherichia coli), and Gram-positive strains (Enterococcus faecalis, Bacillus subtilis, Staphylococcus aureus, and Bacillus cereus) |
Robust inhibition of bacterial growth, particularly in water purification applications |
| Khan et al.102
|
Clinical multidrug-resistant isolates |
Suppression of quorum-mediated virulence factors and biofilm formation in clinical MDR isolates, potential as alternative therapeutic agents |
| Singh et al.34
|
Carbapenem-resistant clinical isolates |
Inhibitory action against carbapenem-resistant clinical isolates, synergistic activity with conventional antibiotics |
| Alotaibi et al.105
|
Pseudomonas aeruginosa clinical isolates |
Significant antibacterial activity against specific clinical isolates, potential for therapeutic applications |
| Krishnamoorthy et al.107
|
β-Lactam-resistant Gram-negative food pathogens |
Broad-spectrum antibacterial activity against specific foodborne pathogens |
| Hayat et al.106
|
Foodborne pathogens |
Significant antibacterial activity against foodborne pathogens, inhibition of biofilm formation and EPS production |
| Abdelbaky et al.108
|
Foodborne pathogenic bacterial strains |
Significant antibacterial potency against specific foodborne pathogenic strains, superior activity against Gram-positive bacteria |
| Husain et al.109
|
E. coli, S. aureus, P. aeruginosa
|
Inhibition and eradication of biofilms formed by specific bacterial strains |
| El-Masry et al.110
|
Enterotoxigenic S. aureus
|
Antibacterial properties against enterotoxigenic S. aureus, reduction of enterotoxin A concentration |
| Álvarez-Chimal et al.111
|
Various bacterial strains |
Sensitivity of various bacterial strains to ZnO-NPs, including specific pathogens |
| Ali et al.112
|
P. aeruginosa
|
Disruption of quorum sensing mechanisms in P. aeruginosa, inhibition of virulence factors and biofilm formation |
| Du et al.113
|
S. aureus
|
Visible-light-driven photocatalytic inactivation mechanism against S. aureus, elucidation of electron transfer role |
| Fadwa et al.114
|
E. coli, A. baumannii
|
Synergistic effects with antibiotics against specific bacterial strains, reduction of biofilm formation and drug resistance |
| Abdelraheem et al.115
|
Methicillin, vancomycin and linezolid resistant |
Antibiofilm and antimicrobial effects against specific methicillin-resistant S. aureus strains |
|
S. aureus (MRSA, VRSA and LRSA) |
